The novel amyloid-beta, p-Tau, and neurofilament light chain (ATN) classification scheme has become a promising system for detecting and diagnosing Alzheimer's disease (AD) in vivo [1-5]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.